Department of Obstetrics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, China.
Department of Fetal Medicine and Prenatal Diagnosis, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China; Obstetrics & Gynecology Institute of Guangzhou, Guangzhou, 510150, China; The Medical Centre for Critical Pregnant care in Guangzhou, Guangzhou, 510150, China; Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou, 510150, China.
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:82-90. doi: 10.1016/j.ejogrb.2020.10.001. Epub 2020 Nov 3.
The purpose of this survey is to evaluate the knowledge of Chinese pregnant women about fetal chromosomal aneuploidy and microdeletion and microduplication syndromes, and Non-invasive prenatal testing (NIPT).
Written questionnaires were distributed to pregnant women who visited the fetal medicine clinic of the third affiliated hospital of Guangzhou medical university. A total of 330 questionnaires were given. Twenty-two questionnaires with incomplete information were excluded from further analysis. The remaining 308 cases were incorporated into the final analysis. Data were analyzed using IBM SPSS Statistics 26. Comparisons between categorical variables were tested by the use of crosstabs and χ 2 test.
Among pregnant women, the recognition of Down syndrome was the highest (93.5 %), followed by maternal serum screening (74.0 %) and NIPT (69.2 %) for chromosomal aneuploidy. The awareness rates of chromosomal microdeletions and microduplications (18.2 %) and monogenic disorders (13.3 %) were the lowest. There were no significant differences in age, education, and conception way between pregnant women (P > 0.05). When asked the opinion on increasing the testing range of NIPT, more than 50 % of pregnant women chose to follow the provider's advice.
More than half of pregnant women lacked knowledge of screening methods for fetal chromosomal abnormalities. Less than 20 % of pregnant women knew microdeletion microduplication syndromes. To enhance the understanding of chromosomal abnormalities can ensure that women can actively choose tests rather than passively agreeing to their provider's recommendations so as to avoid missing the optimal prenatal screening time.
本调查旨在评估中国孕妇对胎儿染色体非整倍体和微缺失微重复综合征以及非侵入性产前检测(NIPT)的认知。
向广州医科大学附属第三医院胎儿医学门诊就诊的孕妇发放书面问卷。共发放 330 份问卷,其中 22 份问卷信息不完整,被排除在进一步分析之外。将其余 308 例纳入最终分析。采用 IBM SPSS Statistics 26 进行数据分析。使用交叉表和 χ2 检验比较分类变量。
在孕妇中,对唐氏综合征的认识最高(93.5%),其次是母体血清筛查(74.0%)和染色体非整倍体的 NIPT(69.2%)。染色体微缺失微重复(18.2%)和单基因疾病(13.3%)的知晓率最低。孕妇的年龄、教育程度和受孕方式之间无显著差异(P>0.05)。当被问及是否增加 NIPT 的检测范围时,超过 50%的孕妇选择听从提供者的建议。
超过一半的孕妇缺乏胎儿染色体异常筛查方法的知识。不到 20%的孕妇知道微缺失微重复综合征。增强对染色体异常的认识,可以确保妇女能够主动选择检测,而不是被动接受提供者的建议,从而避免错过最佳产前筛查时间。